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Abstract
We recently identiﬁed a novel ABC A subclass transporter, ABCA6, in human macrophages. Here, we report the molecular
cloning of an additional ABC A subfamily transporter from macrophages denoted ABCA9. The identiﬁed coding sequence is 4.9 kb
in size and codes for a 1624 amino acid protein product. In accordance with the proposed nomenclature, the novel transporter was
designated ABCA9. The putative full-length ABC transporter polypeptide consists of two transmembrane domains and two nu-
cleotide binding folds and thus conforms to the group of full-size ABC transporters. We identiﬁed alternative ABCA9 mRNA
variants in human macrophages that predict the existence of three truncated forms of the novel transporter. Among the human ABC
A subfamily transporters, ABCA9 exhibits the highest amino acid sequence homology with ABCA8 (72%) and ABCA6 (60%),
respectively. The striking amino acid sequence similarity between these transporter molecules supports the notion that they represent
an evolutionary more recently emerged subgroup within the family of ABC A transporters, which we refer to as ‘‘ABCA6-like
transporters.’’ ABCA9 mRNA is ubiquitously expressed with the highest mRNA levels in heart, brain, and fetal tissues. Analysis of
the genomic structure revealed that the ABCA9 gene consists of 39 exons that are located within a genomic region of 85 kb size on
chromosome 17q24.2. In human macrophages, ABCA9 mRNA is induced during monocyte diﬀerentiation into macrophages and
suppressed by cholesterol import indicating that ABCA9, like other known ABC A subfamily transporters, is a cholesterol-re-
sponsive gene. Based on this information, ABCA9 is likely involved in monocyte diﬀerentiation and macrophage lipid homeo-
stasis.  2002 Elsevier Science (USA). All rights reserved.
ATP-binding cassette (ABC) transporters constitute a
complex group of structurally related multispan trans-
membrane proteins that mediate the translocation of a
broad spectrum of substrates across cellular membranes.
These include ions, peptides, sugars, vitamins, and ste-
roid hormones [1,2]. The subgroup of full-size ABC
transporters is structurally characterized by two nucle-
otide binding folds (NBF) with conserved Walker A and
B motifs, signature sequences, and two transmembrane
domains, each typically composed of six membrane-
spanning segments [3]. The speciﬁcity for the trans-
ported substrates is thought to be determined by the
transmembrane domains, whereas the energy required
for the transmembrane transport is provided by hydro-
lysis of ATP at the two NBF [4]. In the past, some ABC
transporters have been studied extensively based on the
observation that they are capable of mediating multi-
drug resistance in cancer therapy.
In the recent years, evidence has accumulated to
suggest that ABC transporters serve important physio-
logical functions in the cellular transmembrane trans-
port of endogenous lipid substrates [5,6]. This concept
has been supported by work from our laboratory and
others providing evidence that ABCA1, the prototypic
member of the ABC A subfamily [2], is a major regu-
lator of HDL in the circulation which functions as a
facilitator of cellular phospholipid and cholesterol ex-
port [7–10]. Interestingly, leukocyte ABCA1 has been
shown to directly control the recruitment of macro-
phages into tissues and the progression of lesions of
atherosclerosis [11]. Beside ABCA1, the half-size trans-
porter ABCG1 has been implicated in macrophage
cholesterol and phospholipid export [12]. The recent
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ﬁnding that mutations in the half-size transporters
ABCG5 and ABCG8 cause b-sitosterolemia, a rare
autosomal recessive disorder which is characterized by
hyperabsorption of sterols, hypercholesterolemia, de-
creased biliary excretion of dietary sterols, and prema-
ture coronary atherosclerosis [13], has demonstrated a
role for ABC transporters in intestinal sterol uptake
[14,15].
We have recently cloned additional members of the
ABC A-subclass of transporters from human macro-
phages [16–18]. Among these, ABCA7 and ABCA2 ex-
hibit signiﬁcant homology with the phospholipid and
cholesterol export facilitator ABCA1. ABCA7 is strongly
expressed in tissues that are rich in macrophages and
lymphocytes including bonemarrow, thymus, spleen, and
peripheral blood [16]. In contrast, ABCA2 shows the
highest expression in neurologic tissues [19]. The obser-
vation that ABCA2 and ABCA7 are co-regulated with
ABCA1 in response to cholesterol uptake and eﬄux
[16,17,20] suggests roles for these transporters in macro-
phage lipid traﬃcking. In a recent study, we identiﬁed an
additional member of the ABC A-subfamily, designated
ABCA6, which is upregulated during monocyte diﬀer-
entiation into human macrophages [18]. However, unlike
ABCA1, ABCA2, and ABCA7, the expression of this
novel transporter is suppressed during cholesterol uptake
of macrophages [12].
In the present study, we report the complete coding
sequence and genomic structure of the human ABCA9
gene. We demonstrate that the molecular structure of
ABCA9 is highly similar to those ofABCA8 andABCA6,
respectively, and provide evidence for sterol-dependent
regulation of ABCA9 in human macrophages.
Materials and methods
Cell culture and preparation of enzymatically degraded, nonoxidized
LDL. Human monocytes were obtained from healthy donors by
leukapheresis and counterﬂow elutriation [12]. Aliquots of 108 cells
were cultured on plastic petri dishes in macrophage SFM medium
(Gibco BRL, Karlsruhe) and allowed to diﬀerentiate into macrophages
for four days in the presence of 50 ng/ml recombinant human M-CSF
(R&D Systems, Wiesbaden) [12]. Macrophages were incubated in the
presence of enzymatically modiﬁed LDL (eLDL, 40 lg/ml) to induce
sterol loading for an additional 24 h. LDLs (d ¼ 1.006–1.063 g/ml)
were puriﬁed from human plasma obtained from healthy volunteers
according to published standard protocols [12]. The preparation was
performed in a Beckman L-70 ultracentrifuge (70Ti rotor) at 4 C and
densities were adjusted with solid KBr. Lipoprotein fractions were
dialyzed repeatedly in phosphate-buﬀered saline (PBS) containing
5mM EDTA. After the ﬁnal dialysis step (0.15M NaCl), LDL lipo-
proteins were sterilized using a 0.45lm sterile ﬁlter (Sartorius,
G€ottingen). Enzymatically degraded, nonoxidized LDL (eLDL) was
prepared according to the protocol by Bhakdi et al. [21].
Nucleic acid puriﬁcation. Total cellular RNA was isolated from
monocytes/macrophages by guanidium isothiocyanate lysis and CsCl
centrifugation [22] and RNA was quantitated spectrophotometrically.
For preparation of genomic DNA, leukocytes were prepared from
50ml human venous blood (anti-coagulated with EDTA) by centrif-
ugation at 400g. Genomic DNA was extracted from whole cells using
the Qiamp DNA Blood Midi Kit (Qiagen, Hilden).
Cloning of human ABCA9 full-length cDNA. Total RNA from
human mononuclear phagocytes that were allowed to diﬀerentiate for
four days [12] was prepared and aliquots of 1lg were reverse-tran-
scribed in a 20 ll RT reaction using the ﬁrst Strand cDNA Synthesis
Kit for RT-PCR (AMV) (Roche, Mannheim). cDNA was ampliﬁed in
a 50 ll reaction volume using the Taq PCR Core Kit (Qiagen, Hilden)
(cycle proﬁle: 94 C for 20 s, 52–62 C for 45 s, and 72 C for 2–3min).
ABCA9-speciﬁc PCR segments were ampliﬁed utilizing sets of de-
generated primers homologous to areas with high similarity between
the coding regions of ABCA6 and ABCA8, respectively. The sequences
of multiple PCR products contained unique open reading frames and
displayed high overall homology with human ABCA8 and ABCA6,
respectively. Using primers speciﬁc for the identiﬁed sequence frag-
ments, the missing interspersed segments were ampliﬁed. The assem-
bled overlapping ampliﬁcation products contained an open reading
frame which represented the complete coding region of a novel ABC
A-subclass transporter. The ﬂanking ends of the thus identiﬁed cDNA
were PCR cloned using degenerated primers from regions of maximum
homology between ABCA8 and ABCA6. All ampliﬁcation reactions
were sequenced at least in triplicate.
Ampliﬁcation primers which resulted in the identiﬁcation of alter-
native mRNA splice variants were 50-ATGAAGAACAATCATGG
GGTGGCCT-30 (forward), 50-AGACCATCACAAAACCAGTCAG
GACGA-30 (reverse) (ABCA9D+55), and 50-GGTCTCAGGAAAGG
GGACGCAATGA-30 (forward), 50-CAAATGCATTTTGTACCACC
TCTGA-30 (reverse) (ABCA9D+73, ABCA9D) 95), respectively.
Semiquantitative RT-PCR. Semiquantitative RT-PCR was per-
formed as previously published [12]. For this, the ABCA9-speciﬁc
primers were used (50-ATGAAGAACAATCATGGGGTGGCCT-30,
forward;50-AGACCATCACAAAACCAGTCAGGACGA-30, reverse)
yielding a diagnostic fragment of 607 and 662bp, respectively, rep-
resenting the alternatively spliced ABCA9D+55 transcript size.
Equal amounts of input RNA were reverse-transcribed and ampliﬁed
for 25, 30, and 35 cycles, respectively, to monitor that the PCR was
in the exponential phase. Ampliﬁcation of the housekeeping gene
GAPDH served to normalize input RNA amounts (not shown) [17].
PCR ampliﬁcation of intron sequences. PCR cloning of intron se-
quences was performed using the Taq PCR Core Kit (Qiagen, Hilden)
and putative exon-speciﬁc oligonucleotide primers for ABCA9 based
on gene structure information of ABCA6 [18]. One hundred to ﬁve
hundred nanogram aliquots of genomic DNA were ampliﬁed in a 50ll
reaction volume. The reaction mix was composed of 500 nM oli-
gonucleotide primers, 1.5–3mM MgCl2, 200lM dNTP, 10 Qiagen
PCR buﬀer, and 2 units Taq DNA polymerase (Qiagen, Hilden). After
a 2min denaturation step (94 C), reaction mixtures were PCR am-
pliﬁed for 40 cycles using the following cycle proﬁle: 94 C for 20 s, 60–
65 C for 45 s, and 72 C for 5min. Large introns were ampliﬁed using
the Expand Long Template PCR System (Roche, Mannheim) (ac-
cording to manufacturer’s manual). All PCR ampliﬁcation products
were separated on ethidium bromide stained agarose gels. Bands of
interest were excised and the DNA was extracted using the GFX PCR
DNA Puriﬁcation Kit (Amersham, Piescataway) for subsequent se-
quence analysis.
DNA sequencing. Both strands of GFX puriﬁed PCR products were
sequenced on an ABI Prism 310 capillary sequencer (PE Applied
Biosystems, Weiterstadt) as previously described [16]. Cycle-sequenc-
ing reactions were performed with BigDye terminators (DNA Se-
quencing Kit, PE Applied Biosystems), puriﬁed on CentriSep spin
columns, and analyzed by capillary electrophoresis.
Analysis of ABCA9 mRNA expression in human tissues. The tissue-
speciﬁc expression of ABCA9 was characterized using a multiple tissue
RNA master blot containing poly Aþ RNA from various human
tissues (Clontech, Heidelberg). A 0.5-kb probe was generated by RT-
PCR using primers that were derived from a region of minimal
homology between ABCA9, ABCA8, and ABCA6, respectively.
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The PCR primers used were: 50-AGCGTGGGTCAGCAAACATG-30
(forward) and 50-TTCTCCCAGAACTCTGAACC-30 (reverse),
respectively. For signal detection, the probe was radiolabeled with
[a-32P]dCTP (Amersham, Freiburg; Oligolabeling Kit, Pharmacia,
Freiburg) and hybridization and washing were performed according to
published protocols [23]. Subsequently, the tissue blot was quantitated
densitometrically and the individual signal densities were translated
into a linear integer scale ranging from 0 to 4 (0, no expression; 4,
maximum expression) as described previously [18,20].
Computer sequence analyses. For DNA and protein computer an-
alyses, the WWW2 HUSAR GCG software package (DKFZ, Heidel-
berg) was used. Sequence comparisons and protein alignments were
performed using the FASTA and MOTIFS applications, respectively.
Results and discussion
In this study, we report the identiﬁcation of the
complete cDNA sequence and the characterization of
the genomic organization of a novel human ABC
transporter, denoted ABCA9. Moreover, we provide
evidence for the existence of multiple alternative
ABCA9 transcripts and demonstrate their regulation in
response to cholesterol ﬂux in human macrophages.
ABCA9 cDNA and predicted polypeptide structure
Using an RT-PCR strategy based on large sets of
degenerate primers homologous to human ABCA6 and
ABCA8 (see Materials and methods), a 4.9-kb transcript
containing a 4872-bp open reading frame was ampliﬁed
from human macrophage cDNA. The detailed sequence
has been deposited with the GenBank Database (Ac-
cession No. AF423307). The identiﬁed open reading
frame encodes a 1624 amino acid polypeptide with a
calculated molecular weight of approximately 160 kDa
(Fig. 1). Nucleotides 4600–4999 (relative to the trans-
lation start) of the predicted coding region showed
>99% homology with a previously reported EST se-
quence (EST640918), referred to as ABCA9 [24]. Given
this observation and in accordance with the currently
proposed nomenclature for human ABC transporters,
the novel protein was designated ABCA9. During the
preparation of this manuscript, a study came to our
attention demonstrating the identiﬁcation of several
ABC transporters on chromosome 17q24 [25]. Among
others, a cDNA was reported for ABCA9 that is largely
identical with, but at the 50 end, 45 bp shorter than the
ABCA9 mRNA reported here. The ABCA9 molecule
predicted by our results contains two NBF with the
characteristic Walker A and B motifs and a signature
sequence is present in the N-terminal NBF (Fig. 1).
However, similarly as observed for ABCA6 and
ABCA8, respectively, no genuine signature sequence
was identiﬁable in the C-terminal NBF. The ABCA9
amino acid sequence predicts the existence of two
transmembrane domains, each consisting of seven
membrane spanning segments. The length of the pre-
dicted ABCA9 polypeptide is similar to those observed
for ABCA6 (1617 aa) and ABCA8 (1581 aa), respec-
tively, but considerably shorter than that of the other
human ABC A subfamily genes that have as yet been
fully characterized. The latter include ABCA1 (2261 aa)
[20], ABCA2 (2436 aa) [17], ABCR (2273 aa) [26], and
ABCA7 (2146 aa) [16], respectively. Comparison of the
predicted ABCA9 peptide sequence with cloned ABC
full-size transporters revealed strikingly high homolo-
gies with human ABCA8 (72%) and ABCA6 (60%). In
contrast, amino acid identities with other characterized
human ABC A subfamily members including ABCA1
(32%), ABCA2 (32%), ABCR (31%), ABCA7 (34%),
and ABCA3 (33%), respectively, were dramatically
lower. The observations that the transporters ABCA9,
ABCA8, and ABCA6 share extensive amino acid ho-
mologies and, at the same time, bear molecular features
that clearly set them apart from the other known ABC A
family members strongly support the view that these
transporters constitute a distinct ABC transporter sub-
class within the ABC A subfamily. Based on their
striking structural similarities and the ﬁnding that
ABCA9, like ABCA8 and ABCA6, is located on a
common genomic locus on chromosome 17q24 (see be-
low), it is likely that all three transporter genes may have
evolved from each other by gene duplication or have
originated from a common ancestor to form a group of
ABCA6-like transporters.
Identiﬁcation of alternative ABCA9 mRNA variants in
human macrophages
In the course of the cDNA cloning experiments, we
were able to reproducibly amplify an additional band of
0.7 kb size from macrophage cDNA using primers
spanning a segment near the 50 end of the ABCA9
coding region (base positions 303–910). Moreover, in
our eﬀorts to clone the 30 end of the ABCA9 mRNA, we
consistently ampliﬁed three distinct bands ranging from
0.7 to 0.9 kb when primers were used that extended
across cDNA positions 4171–4979 (Fig. 2A). Sequenc-
ing of the additional 0.7 kb band obtained from the 50
end of the coding region revealed that it was speciﬁc for
ABCA9; however, it contained an additional 55 bp be-
tween base positions 800 and 801 of the canonical
cDNA sequence (‘‘ABCA9Dþ 55’’). Comparison with
the genomic ABCA9 sequence (see below) showed that
this site precisely represents the exon 6/exon 7 splice
junction in the canonical ABCA9 transcript and that the
additional 55-bp segment was completely identical to a
sequence located at the 50 end of intron 6 (Figs. 2B and
4). The ABCA9D+55 transcript is thus most likely
generated through the partial retention of intron 6. Se-
quencing of the two additional bands obtained by PCR
ampliﬁcation of the segment corresponding to base pairs
4171–4979 demonstrated that the 0.8-kb band was
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identical with the canonical ABCA9 cDNA sequence.
The 0.9-kb band diﬀered from this sequence in that it
contained a 73-bp insertion representing the entire in-
tron 33 (‘‘ABCA9Dþ 73’’) (Fig. 2B). In contrast, we
found that the short 0.7 kb band represented a transcript
that completely lacked the 95 bp long exon 34
(‘‘ABCA9D 95’’) (Fig. 2B), strongly suggesting that
this transcript is a result of alternative exon skipping.
Interestingly, all three alternative ABCA9 transcripts
we found induce frameshifts which ultimately introduce
Fig. 1. Amino acid sequence of human ABCA9 aligned with its closest homologs ABCA8 and ABCA6, respectively. Amino acids are shown in the
single letter code, gaps due to optimal alignment are represented by dots. Annotations designate Walker motifs and the signature sequence of each of
the two nucleotide binding domains. Shaded amino acids highlight amino acid identities among ABCA9 and ABCA8 ( ) or all three ABC trans-
porters ( ). Canonical Walker A, B motifs and N-terminal signature sequences are indicated ( ). The complete ABCA9 cDNA sequence has been
deposited with the NCBI-GenBank (Accession No. AF423307).
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preterminal stops into the coding region. The
ABCA9D+55, ABCA9D+73, and ABCA9D) 95 tran-
scripts thus predict the existence of three ABCA9
polypeptide variants of 266, 1440, and 1435 aa size, re-
spectively (Fig. 2C). The function of the alternatively
spliced ABCA9 mRNAs is presently unclear. It remains
to be established whether they represent regulatory
mRNAs or whether they are translated in signiﬁcant
quantities into short ABCA9 polypeptide variants in
tissues. Of particular interest in that context is the ob-
servation that the ABCA9D+73 and ABCA9D 95
transcripts code for truncated ABCA9 polypeptides that
contain only one transmembrane domain and the N-
terminal NBF (Fig. 2D).
ABCA9 expression in human macrophages is suppressed
by cholesterol overload
In previous studies, we demonstrated that the ex-
pression of a signiﬁcant number of human ABC
transporters in macrophages is regulated during
monocyte diﬀerentiation into macrophages and by cel-
lular cholesterol transport. Intriguingly, this group of
cholesterol-responsive macrophage ABC transporters
includes the majority of the cloned ABC A-subfamily
members [12,16,17]. To test the hypothesis that gene
expression of ABCA9 is regulated by sterol, freshly
isolated human monocytes were allowed to diﬀerentiate
into macrophages for four days in the presence of
M-CSF and subsequently loaded with enzymatically
modiﬁed LDL (eLDL) [21] for 24 h as previously de-
scribed [17]. We found that the ABCA9 mRNA levels
were upregulated during monocyte diﬀerentiation into
macrophages (Fig. 3). Importantly, loading of macro-
phages with eLDL strongly reduced the expression of
the ABCA9 gene in macrophages (Fig. 3). The induc-
tion of ABCA9 expression during M-CSF-dependent
monocyte diﬀerentiation into macrophages and its
suppression in response to sterol inﬂux suggest roles for
this transporter in macrophage lineage commitment
Fig. 2. Alternative ABCA9 mRNA variants in human macrophages. (A) An additional 0.7 kb band (‘‘ABCA9Dþ 55’’) was consistently ampliﬁed
from human macrophage cDNA using primers spanning a 0.6-kb segment (base positions 491–1098) near the 50 end of the full-length ABCA9
transcript (left). Two additional bands of sizes 0.7 (‘‘ABCA9D 95’’) and 0.9 kb (‘‘ABCA9Dþ 73’’), respectively, were routinely ampliﬁable using
primers that extend across a 0.8-kb segment at the 30 end of the canonical ABCA9 mRNA (base positions 4349–5167) (right). Fragment lengths of
DNA size marker bands are indicated for orientation. (B) The ABCA9Dþ 55 mRNA variant is a result of the alternative retention of a 55-bp
subsegment of intron 6 in the coding sequence (exon 6*). The ABCA9Dþ 73 splice variant originates from the complete retention of intron 33
(73 bp), whereas the ABCA9D) 95 transcript results from the alternative skipping of the complete exon 34 (95 bp) (see also Fig. 4). (C) C-termini of
the truncated polypeptide variants encoded by the alternative ABCA9 mRNAs. Note that the predicted ABCA9 variants ABCA9D+73 and
ABCA9D) 95 contain incomplete C-terminal nucleotide binding cassettes that are truncated downstream of the respective Walker A motifs (bold
face). Newly introduced amino acids due to frameshifts are underlined. Numbers indicate the positions of the respective terminal amino acid. (D)
Schematic structure of ABCA9 polypeptide variants predicted by the alternative transcripts ABCA9D+55, ABCA9D+73, and ABCA9D) 95, re-
spectively. A, B, Walker A and B motifs; S, signature sequence; NBF1, nucleotide binding fold 1.
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and lipid homeostasis. One ﬁnding of note in our ex-
periments is the consistent co-regulation of the canon-
ical ABCA9 transcript and the ABCA9Dþ 55 splice
variant which supports the notion that the abundance
of both mRNAs is controlled by common regulatory
mechanisms.
Among the members of the human ABC A-subfam-
ily, sterol-dependent suppression of gene expression has
also been reported for the recently identiﬁed transporter
ABCA6, a close homolog of ABCA9 [12,18]. Presently,
it is unclear whether the sterol-dependent inhibitory
eﬀect on the expression of both genes occurs at the
transcriptional or post-transcriptional level. The identi-
ﬁcation and functional characterization of the ABCA6
and ABCA9 promoters will help elucidate the molecular
mechanisms that underlie the cholesterol-responsive
regulation of these structurally closely related ABC
A-subclass transporters.
ABCA9 mRNA tissue distribution
The tissue-speciﬁc expression of ABCA9 was char-
acterized using a multiple tissue RNA master blot con-
taining mRNA from various human tissues. Dot blot
analysis shows robust expression of human ABCA9 in a
variety of tissues (Table 1). Highest expression was
found in heart, brain, and fetal tissues (Table 1). The
tissue expression pattern of ABCA9 is similar to that
observed for the structurally related transporter ABCA6
[18]. In contrast to the latter, however, ABCA9 exhibits
signiﬁcantly higher expression levels in fetal tissues, in
particular, in the fetal heart and kidney which suggests
potential roles for this transporter during the develop-
ment of these organs.
ABCA9 gene structure and exon/intron boundaries
Ampliﬁcation of the 50 end of the ABCA9 cDNA using
primers from regions ofmaximum homology between the
cDNAs of ABCA8 and ABCA6 revealed that the
ABCA9 transcription initiation region is located >180 bp
upstream of the translation start site. This strongly sug-
gests that the ABCA9 full-length coding region starts in
the proximity of the 50 end of exon 2. Based on this in-
formation, ABCA9 candidate introns were ampliﬁed
from human genomic DNA using long template PCR.
Exon-speciﬁc primers, based on the comparison of the
known gene structures of human ABCA6 [18], ABCA2
[17], and ABCA1 [27], respectively, were used which
ﬂanked putative ABCA9 exon/intron boundaries. The
exon/intron organization of ABCA9 was assessed by di-
rect sequencing of the respective PCR ampliﬁcation
products. The ﬂanking regions of all intron spanning
ampliﬁcation products showed complete sequence iden-
tity with their respective cDNA counterparts. A total of
39 exons were thus identiﬁed (Table 2). The complete
exon sequences of ABCA9 have been deposited with the
Fig. 3. Downregulation of ABCA9 mRNA in macrophages during
sterol import. Shown is the expression of ABCA9 mRNA by semi-
quantitative RT-PCR in human monocytes and macrophages. Lane 1:
freshly obtained human monocytes. Lane 2: macrophages (Mac)
maintained in culture in the presence of M-CSF for four days. Lane 3:
macrophages as in lane 2 incubated with enzymatically degraded LDL
(eLDL, 40 lg/ml) for an additional 24 h (Mac+ eLDL). Expression of
the housekeeping reference gene GAPDH is shown in the bottom
panel. The sizes of the diagnostic PCR products are 607 (ABCA9), 662
(ABCA9D+55), and 280 bp (GAPDH), respectively. RT-PCR was
performed for 35 ampliﬁcation cycles.
Table 1
RNA expression of ABCA9 and ABCA6 in various human tissues
Tissue Relative mRNA expression
ABCA9 ABCA6
Adrenal gland 
Thymus  
Lung  
Heart  
Skeletal muscle 
Spinal chord  
Corpus callosum  
Substantia nigra  
Spleen  
Lymphnode  
Pancreas 
Placenta 
Colon  
Prostate  
Testis 
Ovary  
Uterus  
Mammary gland 
Thyroid gland  
Kidney  
Liver  
Bone marrow  
Periph. leukocytes  
Fetal heart 
Fetal kidney 
Fetal liver  
Fetal spleen 
Fetal thymus 
Fetal lung  
Gene expression levels for individual tissues were determined by
dot blot analysis and quantitated densitometrically (Materials and
methods). The signal densities were translated into a linear scale (0–4)
and are shown as dots.
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GenBank Database under Accession Nos. AF423308–
AF423346. Exons andmost introns are relatively small in
size comparable to those in the ABCA6 gene. Exon sizes
range from 56 to 227 bp and intron sizes are in the range
from 73 to 11.8 kb (Table 2). The initial and terminal
dinucleotides of all introns showed the GT–AG conﬁg-
uration diagnostic of splice junctions [28]. We found
that the 39 exons of the ABCA9 span a genomic region
of approximately 85 kb (Fig. 4). This structure is in
accordance with the gene sizes reported for other human
ABCA transporters (ABCA1, ABCA2, ABCR, ABCA6,
and ABCA7) whose genomic regions range from 21 to
149 kb [17,18,27,29,30].
Chromosomal assignment of the ABCA9 gene
GenBank database analyses using the FASTA algo-
rithm revealed >99% identity of the whole assessed
Table 2
Exon–intron boundaries of the human ABCA9 gene
Exon Exon size (bp) 50 Splice site 30 Splice site Intron size (kb)
1 175 TCCTGAGAgtaagtta 10
2 109 ttttaaagGAAACAGG CCTTGTTGgtatgctt 1.5
3 208 ctatatagGAATGGCT CCTAAAAGgtatgttc 4.0
4 165 catggcagGAAGAACA CCATTCAGgtaacttt 0.6
5 104 ttctaaagCTCACTGT TCATAGAAgtgagtat 0.8
6 227 ttcttcagATCGCAAC GCATTCTGgtaaatca 8
7 142 tctgctagGCTTTCCT TGTCTTTGgtgagttg 0.2
8 186 tttctcagATAACTTT TGGCCCAGgtaagagt 1.4
9 148 tttttcagCTTATACA TTTGCCCGgtaagtac 1.5
10 169 tcacatagCTGAATAT GCCATCAGgtaaccaa 3
11 59 tttttcagAATCAAAA TTTGAAAGgtaataaa 0.5
12 111 catgccagGTGTGGTG AACATCAGgtaagaag 0.7
13 176 gctttcagGTTCAGTC AGAAAGAGgtatgtga 0.2
14 120 ttgattagGTACAACG ATCCTCAAgtaagtca 0.2
15 139 ctgtccagGTTTTGCT TCTGGCGGgtaatttt 0.5
16 91 ctaactagACAGGAAG CATTTAAGgtacagcc 2.0
17 140 aatgttagTTTGCATC ATTTCCAGgtaacaaa 2.4
18 120 acttttagAACTTTAC TGAATCAGgtaagaaa 1.2
19 199 tgttttagATATTGGA TGGACTATgtgagtat 1.8
20 167 ctgcatagATTATTGC TAAGACAGgtgaacat 0.6
21 134 tcatgtagGGTCAACC ATGAAAAGgtatgctg 1.3
22 138 tatttcagGATCACAG TTTTTGAAgtaagtat 4
23 108 gatttcagGAGCATAT ACTACAAAgtaagaag 4
24 174 tttatcagAAAAAAGC TAATTCAAgtaagtgg 0.2
25 114 gttttcagATCCTGTG TCTTAATTgtgagtat 12
26 120 tgttttagGTGGTCAT TTTCTGAGgtaagtag 3
27 69 ttttacagATTTCTCC TGCTAATAgtaagaag 0.8
28 92 ttccctagCCTTACCT GTGTTCAGgttgagaa 1.2
29 121 gatttcagAATTTCTC TTGATGAGgtagaact 0.9
30 118 ctttacagACACCCGT TAAAAAAGgttggaaa 0.7
31 92 tctttcagGTGAAGTT CAGGACAGgtcagtaa 3
32 161 ttgcatagGTGATTTT ATCACACGgtacctgg 1.0
33 76 ttcttcagGTTAGTGG AGCGAAAGgtacgggc <0.1
34 94 cgttgcagCTGTGCTT CAAATGTGgtgaggtg 0.7
35 120 aactttagGCAGGTGA AGGCTGAGgtgagtgc 0.2
36 141 accttcagATGTATTG CAGGAAAGgtagacac 1.1
37 80 cttcgcagGTTCTCCT AGAGATAGgtaagagt 6
38 56 ttatgcagTTAAACAG TGGAGCAGgtgggtca 0.1
39 223 ccttttagGTTTTCCT
Fig. 4. Structural organization of the ABCA9 gene on chromosome 17q24.2. Exons are numbered in 50 to 30 order and shown as black boxes. The
alternative exon 6* (a), the retained intron 33 (b), and the alternatively skipped exon 34 are represented by open boxes. A metric scale bar is indicated.
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ABCA9 gene sequence with a genomic sequence (Ac-
cession No. AC005922). Using the Genome Browser
software (http://genome.ucsc.edu), we allocated this
contig to the chromosomal region 17q24.2-3, strongly
suggesting that the ABCA9 gene is localized at this
chromosomal site. Interestingly, we could assign the loci
for the ABCA8 and ABCA6 genes, the closest known
homologs of ABCA9, to the same chromosomal region.
This indicates that the ABCA9, ABCA8, and ABCA6
genes share a common region on chromosome 17q24.
Importantly, detailed screening of this genomic region
for coding sequences revealed that two additional genes
encoding bona ﬁde ABC transporters co-localize to
this very genomic microenvironment (manuscript in
preparation).
In conclusion, we have identiﬁed a novel member of
the ABC A-subfamily of full-size transporters, desig-
nated ABCA9, which represents the third member of the
group of ABCA6-like ABC transporters. Moreover, we
provide evidence for the existence of multiple mRNA
variants potentially coding for truncated ABCA9 pep-
tides in human macrophages. Our results demonstrating
that the ABCA9 expression is induced during monocyte
diﬀerentiation into macrophages and inhibited by cho-
lesterol inﬂux in human macrophages suggest that this
novel transporter, like ABCA6, may serve functions in
macrophage diﬀerentiation and lipid traﬃcking. Further
work is required to determine the precise biological
function of ABCA9 in transmembrane transport, in
particular in the context with its close relatives ABCA8
and ABCA6. It will be particularly challenging to test
whether and to which extent ABCA9 is implicated in
fetal development.
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